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Herpes zoster ophthalmicus (HZO) with oculomotor nerve involvement is rare, even rarer as an acute presentation rather than
sequelae of HZO. In this paper we present a case of cutaneous HZO in which our patient’s initial presentation was one of complete
ophthalmoplegia.
1.Introduction
Herpes zoster (or shingles) refers to a typically vesicular rash
caused by reactivation of the latent varicella zoster virus
(chickenpox) fromthe dorsal root ganglia neurons. It usually
presents in thoracic or cranial dermatoms. The lifetime risk
of herpes zoster is estimated to be 10% to 20%, but in
patients over the age of 80 years this risk rises to 50%.
Reactivation can occur for a number of diﬀerent reasons
including trauma, ageing, or immune deﬁciency [1].
HZO is a rare form of shingles, reported in 15–25% of
cases [2], that presents with a rash in the distribution of
the trigeminal nerve dermatomes (mainly ophthalmic and
maxillarydivisions). Itisoftenreported tobeassociatedwith
a variety of complications, including episcleritis, keratitis,
glaucoma, and cataracts [1], but there are very few reports
of complete ophthalmoplegia being one of those.
2. Case Presentation
An 87-year-old lady who lives alone presented to the medical
admissions unit with an inability to open her right eye. She
has a past history of mild dementia and depression and was
previous to this otherwise ﬁt and well. She describes a 6-
day history of blister formation surrounding the eye that
extends to her right forehead and scalp. Her family noticed
her eye was becoming increasingly droopy, red, and swollen
culminating in it being permanently shut for twenty-four
hours prior to admission. This visual impairment was most
likely responsible for her falling before attending hospital,
during which she sustained a left elbow laceration. Of note,
she had been started two days previously on ﬂucloxacillin
and phenoxymethylpenicillin by her general practitioner.
On examination she had a vesicular rash covering her
right scalp, forehead, eye, and upper cheek. It was erythe-
matous,swollen,andtender.Shehadacompleteophthalmo-
plegia, and her pupil was ﬁxed and dilated. Her visual acuity
in that eye was reduced to counting ﬁngers. The remainder
of her neurological and other systems examinations were
normal. She was commenced on oral and topical acyclovir,
dexamethasone, and cyclopentolate subsequent to ophthal-
mology review. There was no evidence of vasculitis on slit-
lamp examination (see Figures 1 and 2).
The vesicular rash resolved some two weeks later after
admission, and she was discharged. She had regained some
of her eye movements partially but the ptosis remained.
3. Discussion
In the limited literature, that does report opthalmoplegia as
part of the sequelae of HZO, this has typically been described
as a late complication, often up to 2 months after the initial
herpetic rash [3] and is seen in only 11–29% of patients
with HZO. However, in our case it has developed as part of2 Case Reports in Ophthalmological Medicine
Figure 1: Oculomotor nerve palsy-pupil ﬁxed and dilated in a
position of lateral and downward gaze.
Figure 2: To show the rash in the distribution of the ophthalmic
branch of the trigeminal nerve.
the acute viral infection. The most commonly aﬀected nerve
is the third cranial nerve and, less commonly, the fourth
nerve [4]. With a third nerve palsy it has been reported as
being partial or complete but there is always ptosis. Isolated
ptosis and isolated paralysis of the pupil have also been seen
[5]. In our case, there was third cranial nerve (oculomotor)
palsy causing complete external ophthalmoplegia, with her
pupil ﬁxed and middilated.
Several hypotheses have been proposed for the mecha-
nism behind which HZO can result in ophthalmoplegia [5–
8] although it is most likely that there are many contributing
factors. It is known that the reactivated virus causes inﬂam-
mation of the axons that supply the dermatomes in question.
Edgerton suggested that the inﬂammation of the trigeminal
nerve could actually spread via the cavernous sinus to aﬀect
theoculomotornerve[5].Inaddition, Naumannetal.found
chronic inﬂammatory cells suggesting an occlusive vasculitis
[6].Carrolthoughtthatduetotheonsetandrateofrecovery,
this pathology would suggest a demyelinating disease, and
Lavin et al. were in agreement with this hypothesis based on
autopsy reports [7, 8].
Diagnosis of this condition is essentially a clinical
one based on history and examination ﬁndings. Once the
diagnosis is made, it is reported that the earlier treatment
is initiated, the better the prognosis is, preferably within
72 hours, although beneﬁcial eﬀects have been reported
with treatment started as late as 7 days after onset [9].
Acyclovir, famciclovir or valacyclovir have all been used,
and they act by resolving skin lesions, decreasing viral
shedding and decreasing the risk of ocular involvement.
Some report that famciclovir and valacyclovir are better
at resolving pain associated with HZO than acyclovir [9].
In addition to the antivirals it is important to treat any
further complications detected. For example, if keratitis
or episcleritis has developed, then topical steroids can be
used. The eﬀectiveness of steroids and antivirals alone or
in combination does not, however, appear to have been
formally studied, and treatment options are limited partly
due to the poorly deﬁned mechanism of HZO.
The prognosis for full recovery after complete opthalmo-
plegia following HZO is good. In one literature review, of 16
total cases, 9 were followed up, and all of those cases showed
signiﬁcant improvement in symptoms after 2 months and
almost complete resolution by 18 months [10].
4. Conclusion
Ophthalmoplegia is a rare complication of HZO. Further-
more, the cases in the literature describe it as relatively late
sequelae, unlike the acute presentation we have reported.
Abbreviation
HZO: Herpes zoster ophthalmicus.
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